Whitehawk Therapeutics, Inc. (WHWK)
NASDAQ: WHWK · Real-Time Price · USD
3.590
0.00 (0.00%)
At close: Mar 20, 2026, 4:00 PM EDT
3.590
0.00 (0.00%)
After-hours: Mar 20, 2026, 4:27 PM EDT

Whitehawk Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
7.1525.9824.3515.221.12
Revenue Growth (YoY)
-72.50%6.69%60.05%1258.57%-92.32%
Cost of Revenue
0.763.022.811.34-
Gross Profit
6.3922.9621.5513.88-
Selling, General & Admin
29.8236.7544.5540.1818.51
Research & Development
90.9651.0348.9332.6619.67
Other Operating Expenses
-2.64-3.7274.16
Total Operating Expenses
120.7990.4293.4876.56112.34
Operating Income
-114.4-67.46-71.93-62.68-111.22
Interest Income
6.233.936.42.40.01
Interest Expense
--0.15-0.23-0.23-0.67
Other Non-Operating Income (Expense)
87.57-0-0-1.78
Total Non-Operating Income (Expense)
93.83.776.172.171.13
Pretax Income
-20.6-63.69-65.77-60.51-110.09
Provision for Income Taxes
-----0
Net Income
-20.6-63.69-65.77-60.51-110.74
Net Income Attributable to Preferred Dividends
----0.65
Net Income to Common
-20.6-63.69-65.77-60.51-110.74
Shares Outstanding (Basic)
622727239
Shares Outstanding (Diluted)
622727239
Shares Change (YoY)
128.96%0.42%19.58%152.27%250.99%
EPS (Basic)
-0.33-2.36-2.44-2.69-12.41
EPS (Diluted)
-0.33-2.36-2.44-2.69-12.41
Free Cash Flow
-97.99-61.2-63.64-50.08-22.47
Free Cash Flow Per Share
-1.58-2.26-2.36-2.22-2.52
Gross Margin
89.36%88.36%88.47%91.23%100.00%
Operating Margin
-1601.12%-259.62%-295.36%-411.94%-9930.09%
Profit Margin
-288.26%-245.13%-270.04%-397.69%-9829.46%
FCF Margin
-1371.38%-235.55%-261.29%-329.15%-2006.16%
EBITDA
-114.32-67.27-71.76-62.52-111.11
EBITDA Margin
-1600.01%-258.88%-294.67%-410.90%-9920.71%
EBIT
-114.4-67.46-71.93-62.68-111.22
EBIT Margin
-1601.12%-259.62%-295.36%-411.94%-9930.09%
Effective Tax Rate
0.00%0.00%0.00%0.00%0.00%
Updated Mar 12, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q